Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Diao L, Hang Y, Othman AA, Mehta D, Amaravadi L, Nestorov I, Tran JQ
Br J Clin Pharmacol. 2016 Jun 22. PMID: 27333593.Abstract